Sunday, June 28, 2026

President Empowers Unification Ministry As Lead Department, Pursues Appointment Of Chief Representative To North

President Lee Jae Myung endorses the Ministry of Unification for North Korea policy, proposing a Special Envoy for peace talks.

Amazon Opens New AI and Tech Hub in Singapore

AWS launched its Asia-Pacific Innovation Hub in Singapore to boost AI innovation, showcasing advanced tech for executives and students.

From Scratch to Success: How Trillion Labs is Redefining AI with Their 70B Parameter Model

Trillion Labs aims to join the government's AI project, showcasing its independent model development and commitment to open-source innovation.

Classys Showcases Expanding Aesthetics Portfolio at ASLMS 2026 as U.S. Push Accelerates

HealthClassys Showcases Expanding Aesthetics Portfolio at ASLMS 2026 as U.S. Push Accelerates
A view of the Classys booth at ASLMS 2026 held in Savannah, Georgia, U.S. / Provided by Classys
A view of the Classys booth at ASLMS 2026 held in Savannah, Georgia, U.S. / Provided by Classys

Global medical aesthetics company Classys recently participated in the 45th Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) in Savannah, Georgia, the company announced on Monday.

Classys has been rapidly expanding its global market presence, anchored by its high-frequency device Everesse (known as Volnewmer in the U.S.). The company has further bolstered its robust two-pronged portfolio with the addition of Quadessy (QUADESSY), a next-generation microneedling RF device launched in the U.S. in March 2026.

Classys aims to shake up the existing competitive landscape in the U.S. market by offering a comprehensive lineup. This includes the soon-to-be-released laser Reepot (REEPOT) slated for launch this year, and the High-Intensity Focused Ultrasound (HIFU) device Ultraformer MPT (marketed internationally as Shurink Universe) set for a 2027 debut. Together, these offerings will cover the full spectrum of aesthetic treatments, from skin lifting to pigmentation correction.

With its participation in ASLMS 2026, Classys intends to accelerate its expansion in the U.S. market.

The company’s strategy goes beyond single-product focus. Instead, Classys aims to maximize clinical utility through an integrated portfolio based on multiple platforms. This approach allows for versatile treatment combinations and tailored patient solutions, setting Classys apart in the market.

A Classys spokesperson emphasized that for them, the U.S. market isn’t just about gaining a foothold; it’s a key strategic arena where we must establish leadership. It’s poised to rapidly expand the market influence through the technologically advanced and clinically proven portfolio, setting new benchmarks in the global energy-based device market.

Classys, founded in 2007, is a global leader in medical aesthetics, currently supplying state-of-the-art aesthetic medical devices to over 80 countries worldwide.

The company has cultivated a diverse energy-based device (EBD) portfolio, featuring: the globally top-ranked Shurink Universe, a focused ultrasound (HIFU) lifting device; Volnewmer, a cutting-edge monopolar radiofrequency (MRF) volumizing solution; Quadessy, an advanced microneedle radiofrequency (MNRF) system; the Reepot laser device; and Shurink Home Lift to Glow, a home beauty device leveraging medical-grade technology.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles